Panos Zanos, Ph.D.

Affiliations:	2014-2021	Psychiatry	University of Maryland School of Medicine, Baltimore, MD, United States
	2021-	Psychology	University of Cyprus, Nicosia, Nicosia, Cyprus

Area:

opioid addiction, ketamine, rodent models, rapid-acting antidepressants, substance use disorders

Website:

https://zanoslab.com/

Google:

"Panos Zanos"

Bio:

Dr. Zanos is a prominent figure in brain disease research, focusing on innovative therapies for major depressive disorders and related conditions. His groundbreaking work, particularly on the use of ketamine metabolites as rapid-acting antidepressants, has shown promise in transforming depression treatment. Notably, his discoveries have led to a phase I clinical trial with positive outcomes, paving the way for a phase II trial. Despite being an early career researcher, Dr. Zanos has achieved remarkable accomplishments, securing significant grant funding and publishing over 60 peer-reviewed articles in prestigious journals. His research has gained global recognition, with collaborations and partnerships with influential figures in addiction and depression research. Additionally, Dr. Zanos is involved in a groundbreaking clinical trial on ketamine's efficacy in preventing opioid relapse, marking a milestone in Cyprus. Beyond ketamine research, he has contributed to neuropharmacology, exploring oxytocin's role in drug addiction and investigating receptor interactions, genetic vulnerabilities, and sleep disorders in mental health conditions.
(Show less)

Mean distance: (not calculated yet)